Nektar Therapeutics

NASDAQ:NKTR

0.9512 (USD) • At close December 26, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994
Revenue 90.12292.055101.907152.915114.6171,193.323307.711165.436230.784200.707148.92181.19171.48159.03971.93190.185273.027217.718126.279114.27106.25794.84577.46851.62941.35821.79516.2496.93.41.7
Cost of Revenue 36.64421.63524.89719.47721.37424.41230.54730.21534.10228.53338.50930.42821.89125.66730.94835.037147.517118.08935.99619.79814.6787.024.1690000-1.2-1.1-0.5
Gross Profit 53.47870.4277.01133.43893.2431,168.911277.164135.221196.682172.174110.41250.76349.589133.37240.98355.148125.5199.62990.28394.47291.57987.82573.29951.62941.35821.79516.2498.14.52.2
Gross Profit Ratio 0.5930.7650.7560.8730.8140.980.9010.8170.8520.8580.7410.6250.6940.8390.570.6110.460.4580.7150.8270.8620.9260.94611111.1741.3241.294
Reseach & Development Expenses 114.162218.323400.269408.678434.566399.536268.461203.801182.787147.734190.01148.675126.766108.06595.109154.417153.575149.381151.659133.523131.528157.383139.651101.54464.08335.39823.64514.490
General & Administrative Expenses 77.41792.333122.844104.68298.71281.44352.36444.27543.26640.92540.53241.61446.7640.98641.00651.49756.33678.31943.85230.96722.01726.01618.86113.9327.8698.3876.328400
Selling & Marketing Expenses 000000000000000000000000000000
SG&A 77.41792.333122.844104.68298.71281.44352.36444.27543.26640.92540.53241.61446.7640.98641.00651.49756.33678.31943.85230.96722.01726.01618.86113.9327.8698.3876.32843.27.4
Other Expenses 0-0.116-24.4100000000.3920.983000-68.114-48.25331.15969.5463.9244.2194.50725.4900001.24.37.9
Operating Expenses 190.903310.656523.113513.36533.278480.979320.825248.076226.053188.659230.542190.289173.526149.051136.115137.8161.658258.859265.057168.414157.764187.906184.002115.47671.95243.78529.97319.613.37.9
Operating Income -137.425-240.236-446.103-379.922-440.035687.932-59.642-112.855-29.371-16.485-120.13-141.201-123.937-28.255-95.132-82.652-36.148-159.23-182.633-73.942-66.185-100.081-256.963-66.139-40.484-21.99-13.724-11.5-8.8-5.7
Operating Income Ratio -1.525-2.61-4.378-2.485-3.8390.576-0.194-0.682-0.127-0.082-0.807-1.739-1.734-0.178-1.323-0.916-0.132-0.731-1.446-0.647-0.623-1.055-3.317-1.281-0.979-1.009-0.845-1.667-2.588-3.353
Total Other Income Expenses Net -138.831-124.747-77.177-64.025-0.019-5.207-36.434-39.793-51.3-37.943-39.638-30.248-9.023-8.802-7.6447.514.6965.297-2.615-28.10719.672-7.3876.955-31.264-9.89001.61.30.6
Income Before Tax -276.256-364.983-523.28-443.947-440.054682.725-96.076-152.648-80.671-54.428-159.768-171.449-132.96-37.057-102.77235.142-31.452-153.933-185.248-102.049-46.513-107.468-250.008-97.403-50.37400-9.9-7.5-5.1
Income Before Tax Ratio -3.065-3.965-5.135-2.903-3.8390.572-0.312-0.923-0.35-0.271-1.073-2.112-1.86-0.233-1.4290.39-0.115-0.707-1.467-0.893-0.438-1.133-3.227-1.887-1.21800-1.435-2.206-3
Income Tax Expense -0.23.2150.5570.4930.6131.4120.6160.8760.506-0.5122.2450.4061.0180.881-0.253-0.8061.3090.828-0.137-0.1630.1697.387139.30533.5567.854-3.634-3.741-1.5-1.1-0.4
Net Income -276.056-368.198-523.837-444.44-440.667681.313-96.692-153.524-81.177-53.916-162.013-171.855-133.978-37.938-102.519-34.336-32.761-154.761-185.111-101.886-46.682-107.468-250.008-97.403-38.448-18.356-9.983-10-7.7-5.3
Net Income Ratio -3.063-4-5.14-2.906-3.8450.571-0.314-0.928-0.352-0.269-1.088-2.117-1.874-0.239-1.425-0.381-0.12-0.711-1.466-0.892-0.439-1.133-3.227-1.887-0.93-0.842-0.614-1.449-2.265-3.118
EPS -1.45-1.97-2.86-2.49-2.523.78-0.62-1.1-0.61-0.42-1.4-1.5-1.19-0.4-1.11-0.37-0.36-1.72-2.15-1.3-0.84-1.94-4.71-2.32-1.13-0.58-0.36-0.44-0.39-0.43
EPS Diluted -1.45-1.97-2.86-2.49-2.523.78-0.62-1.1-0.61-0.42-1.4-1.5-1.19-0.4-1.11-0.37-0.36-1.72-2.15-1.3-0.84-1.94-4.71-2.32-1.13-0.58-0.36-0.44-0.39-0.43
EBITDA -243.107-323.872-462.967-394.329-382.7734.303-42.522-97.268-29.371-2.744-106.006-124.103-107.786-9.332-75.7152.539-7.12-125.721-147.069-54.755-47.768-81.112-70.318-53.723-23.34-18.392-11.286-10.3-7.7-5.2
EBITDA Ratio -2.698-2.396-4.453-2.272-3.320.617-0.079-0.575-0.064-0.014-0.703-1.499-1.4930.015-1.064-1.979-0.214-0.467-0.584-0.401-0.753-0.8451.034-0.227-0.325-0.844-0.695-1.725-2.647-3.412